课题基金 / 基金详情

THERAPEUTIC TRIAL OF HIVIG IN CHILDREN WITH PROGRESSIVE DISEASE

THERAPEUTIC TRIAL OF HIVIG IN CHILDREN WITH PROGRESSIVE DISEASE
HIVIG 对疾病进展儿童的治疗试验
批准号:
6280829
负责人:
ANN PETRU
金额:
$2.39万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

ANN PETRU的其他基金

相似基金

相关文献

中文摘要
翻译
本试验旨在确定高滴度HIV(HIVIG)抗体是否 有效地减缓艾滋病毒感染的进展,它是基于 假设HIVIG会降低病毒负荷。 初步研究表明,延长用药前和用药后 机会性感染的数量减少,生存率提高。 最 研究表明, 而有些人表现出较少的血浆病毒血症。
英文摘要
This trial is to determine whether high-titer HIV (HIVIG) antibody is effective in slowing the progression of HIV infection, and it is based upon the hypothesis that HIVIG will decrease the viral burden. Preliminary studies showed some benefit with prolonged time before and fewer numbers of opportunistic infections and improved survival. Most studies have shown a significant drop in the amount of virus circulating and some showed less plasma viremia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LATE OUTCOMES FOR TREATMENT OF HIV INFECTION
EFFECT OF ANTIRETROVIRAL THERAPY ON BODY COMPOSITION IN CHILDRENPACTG 1010
ACTG P1024
ACTG P1024 EVALUATION OF THE IMMUNOGENICITY OF PNEUMOCOCCAL CONJUGATE VACCINE...
海外基金